Clinical Trial Update: Autologous Stem Cell Transplant for Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous stem cell transplantation for multiple sclerosis has completed, sponsored by the Ottawa Hospital Research Institute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED